Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Inventory (2021 - 2024)

Goldenwell Biotech's Change in Inventory history spans 4 years, with the latest figure at $73.0 for Q4 2024.

  • For Q4 2024, Change in Inventory rose 103.26% year-over-year to $73.0; the TTM value through Dec 2024 reached $83.0, up 104.46%, while the annual FY2024 figure was -$75.0, 93.72% up from the prior year.
  • Change in Inventory reached $73.0 in Q4 2024 per GWLL's latest filing, up from -$69.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $103125.0 in Q1 2021 to a low of -$20663.0 in Q3 2022.
  • Average Change in Inventory over 4 years is $15692.3, with a median of -$103.5 recorded in 2023.
  • The largest YoY upside for Change in Inventory was 2607.04% in 2022 against a maximum downside of 293.58% in 2022.
  • A 4-year view of Change in Inventory shows it stood at -$1804.0 in 2021, then skyrocketed by 2607.04% to $45227.0 in 2022, then tumbled by 104.95% to -$2240.0 in 2023, then soared by 103.26% to $73.0 in 2024.
  • Per Business Quant, the three most recent readings for GWLL's Change in Inventory are $73.0 (Q4 2024), -$69.0 (Q2 2024), and $79.0 (Q1 2024).